Orticumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Orticumab
Monoclonal antibody
Type Whole antibody
Source Human
Target oxLDL
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none

Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.[1]

References[edit]

  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).